Celularity (CELUW) Enterprise Value (2018 - 2025)
Celularity (CELUW) reported Enterprise Value of -$6.2 million for Q4 2025, down 736.72% year-over-year from $969812.7 in Q4 2024, and down 5045.83% quarter-over-quarter from -$120000.0 in Q3 2025.
Celularity (CELUW) Enterprise Value (2018 - 2025) Analysis & Trends
Celularity (CELUW) has 8 years of Enterprise Value data on file, last reported at -$6.2 million in Q4 2025.
- Enterprise Value for Q4 2025 came in at -$6.2 million, down 736.72% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.2 million (down 736.72% YoY), and the FY2025 annual result was -$6.2 million, down 736.72% from the prior year.
- Enterprise Value retreated to -$6.2 million in Q4 2025 per CELUW's latest filing, from -$120000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$211.0 in Q2 2021 and troughed at -$72.7 million in Q3 2021.
- A 5-year average of -$13.8 million and a median of -$1.4 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 18007482.94% in 2022, then soared 99.36% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$37.2 million in 2021, then soared by 62.5% to -$14.0 million in 2022, then jumped by 98.37% to -$227000.0 in 2023, then plunged by 225.11% to -$738000.0 in 2024, then sank by 736.72% to -$6.2 million in 2025.
- Business Quant data shows CELUW's Enterprise Value at -$6.2 million in Q4 2025, -$120000.0 in Q3 2025, and -$863000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Celularity | - | - | -3.27 Mn | -6.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.18 Mn |
| Sep 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -863,000.00 |
| Mar 31, 2025 | -293,000.00 |
| Dec 31, 2024 | -738,000.00 |
| Sep 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -467,000.00 |
| Mar 31, 2024 | -1.90 Mn |
| Dec 31, 2023 | -227,000.00 |
| Sep 30, 2023 | -273,000.00 |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | -8.53 Mn |
| Dec 31, 2022 | -13.97 Mn |
| Sep 30, 2022 | -42.65 Mn |
| Jun 30, 2022 | -38.00 Mn |
| Mar 31, 2022 | -48.04 Mn |
| Dec 31, 2021 | -37.24 Mn |
| Sep 30, 2021 | -72.72 Mn |
| Jun 30, 2021 | -211.00 |
| Mar 31, 2021 | -28,654.00 |